SCHEMBL1399425

SCHEMBL1399425

Cc1cccc2[nH]cc(Sc3ccc(F)cc3CCN)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.49
MPO P05164 4/20 0.45
TRPM8 Q7Z2W7 1/20 0.45
HTR1A P08908 1/20 0.44
KMT2A Q03164 1/20 0.44
GPR84 Q9NQS5 1/20 0.43
HTR2C P28335 2/20 0.42
IDO1 P14902 1/20 0.42
TAAR1 Q96RJ0 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2A6 P11509 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR7 P34969 1/20 0.40
CTSK P43235 1/20 0.40
HTR6 P50406 1/20 0.40
CYP2A13 Q16696 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1399427 0.89 HTR2A (0.59) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399451 0.87 HTR2A (0.63) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399390 0.86 HTR2A (0.49) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399270 0.86 HTR2A (0.49) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399394 0.86 GPR84 (0.46) HTR2AMPOGPR84IDO1SLC6A2
SCHEMBL1399423 0.82 HTR2A (0.57) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399358 0.82 HTR2A (0.50) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399206 0.81 HTR2A (0.58) HTR2AMPOTRPM8HTR1AKMT2A
SCHEMBL1399252 0.80 IDO1 (0.48) HTR2AMPOTRPM8GPR84HTR2C
SCHEMBL1399314 0.79 HTR2A (0.62) HTR2ATRPM8HTR1AHTR2CIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1860100-B1 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI LUNDBECK & CO AS H (DK) 2011-03-02 EP claimed